BioCell® M16
Mazzoleni has developed BioCell®, an innovative probiotic strain (Saccharomyces cerevisiae DBVPG 48 SF), approved in 2024 by the European Community as a feed additive. This strain, selected from natural substrates such as grape berries, ensures uniqueness, high vitality, and fermentative effectiveness measured in colony-forming units (CFU) per gram.
The BioCell® project required six years of research, 18 field trials involving 1,700 animals, and collaboration with seven research institutes across four European countries. The strain selection process considered multiple factors: chemical-physical and genetic characterization analyses were performed, along with tests to evaluate fermentative activity, stability, probiotic potential, and animal performance.
Micropellet with a high concentration
of cells (1.6 x 1010 CFU/g
Saccharomyces cerevisiae DBVPG 48
SF) for use in non-pelleted feed.
